MENU
RLYB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rallybio (RLYB) Ownership - Who owns Rallybio?
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more
Profile
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.26M
P/E Ratio
N/A
Total Cash
54.5M
Projected Growth
N/A
Total Debt
116K
Revenue
848K
Risk (Beta)
-1.16
Dividend Yield
N/A
Total Cash/Share
1.31
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
RLYB
Capitalization
21.3M
P/E Ratio
N/A
Risk (Beta)
-1.16
Dividend Yield
N/A
Total Cash
54.5M
Total Cash/Share
1.31
Total Debt
116K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
848K
ROE
N/A
Book Value
54.1M
P/B Ratio
0.39
Cash Flow
N/A
Earnings
-1.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
14.68
Current Revenue Per Employee
8833.33
Dividends Per Share - Security
N/A
EBITDA
-50.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-61.25
Shares Held By Institutions
20.1M
Shares Outstanding - Current
41.6M
Total Liabilities
3.91M
Total Volume MTD
N/A
Value
1
Gain YTD
-45.031
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLYB showed earnings on May 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com